News | September 10, 2024
Briefs: Wanbury and Bafna Pharmaceuticals
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
TABRECTA is the brand of Novartis. Natco believes it is the first company to have filed a substantially-complete ANDA
Valbenazine Capsules had annual sales of US $1,993.6 mn in the United States (IQVIA MAT June 2024)
This strong performance was primarily on account of a one-time gain from the strategic collaboration between Biocon Biologics and Eris Lifesciences.
Nearly 200 participants from 50 Unani Academia and Council participated
The product is bioequivalent and therapeutically equivalent to the reference listed drug
The innovative ‘Street Safe’ Rapid Testing Kit should be provided to all vendors attending the Food Safety and Certification (FoSTaC) trainings to ensure that safe food is used by the street food vendors across the country
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
The Unit has been issued GMP Certification from ANVISA-Brazil
Subscribe To Our Newsletter & Stay Updated
